AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Oct 16, 2015
29828_dirs_2015-10-16_4034d9f2-f088-4168-b796-0cfc0d7e2739.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-10-15
Reporting Person: BISCHOFBERGER NORBERT W (EVP, R&D and CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-10-15 | Common Stock | M | 68400 | $23.60 | Acquired | 233568 | Direct |
| 2015-10-15 | Common Stock | M | 1600 | $23.755 | Acquired | 235168 | Direct |
| 2015-10-15 | Common Stock | S | 3200 | $98.0171 | Disposed | 231968 | Direct |
| 2015-10-15 | Common Stock | S | 26105 | $99.246 | Disposed | 205863 | Direct |
| 2015-10-15 | Common Stock | S | 15376 | $99.961 | Disposed | 190487 | Direct |
| 2015-10-15 | Common Stock | S | 25319 | $101.1789 | Disposed | 165168 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-10-15 | Non-Qualified Stock Option (right to buy) | $23.60 | M | 68400 | Disposed | 2019-01-21 | Common Stock (68400) | Direct |
| 2015-10-15 | Non-Qualified Stock Option (right to buy) | $23.755 | M | 1600 | Disposed | 2020-01-28 | Common Stock (1600) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $97.62 to $98.54. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $98.63 to $99.62. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request
F5: Sale prices reported for the transactions reported here range from $99.63 to $100.59. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $100.64 to $101.625. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.